Investment Summary |
|
|---|---|
| Date | 2013-09-12 |
| Target | Covagen AG |
| Sector | Life Science |
| Investor(s) | GIMV |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 83 of 170 |
| Sector: Life Science M&A | 12 of 24 |
| Type: Venture M&A Deals | 26 of 39 |
| Country: Switzerland M&A | 2 of 5 |
| Year: 2013 M&A | 9 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-05 |
Astex Pharmaceuticals
Dublin, California, United States Astex Pharmaceuticals, Inc. is a provider of drug discovery, development and commercialization, committed to the fight against cancer and other life threatening diseases. |
Sell | $886M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-27 |
Almaviva Sante
Puyrucard, France Almaviva Sante is a provider of healthcare services to regional centers of expertise (e.g. orthopedics, ophthalmology, cardiology, dialysis). Almaviva was founded in 2007 and is based in Puyrucard, France. |
Buy | - |
